Related Experiment Video
Updated: Aug 8, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 16, 2013
Influence of exogenous interleukin-2 concentration on the isolation of human immunodeficiency virus
B Zöllner1, H H Feucht, A Hamann
1Institut für Medizinische Mikrobiologie und Immunologie, Universitätsklinikum Eppendorf, Hamburg, Germany.
Insights
Using 10 U/ml of interleukin-2 (IL-2) significantly improved human immunodeficiency virus (HIV) isolation rates from plasma. This concentration enhanced sensitivity, particularly in patients negative for p24 core antigen.
Area of Science:
- Virology
- Immunology
Background:
- Accurate isolation of human immunodeficiency virus (HIV) is crucial for diagnosis and research.
- Optimizing laboratory methods can improve detection rates, especially in early or low-viral-load stages of infection.
Purpose of the Study:
- To determine the optimal concentration of exogenous interleukin-2 (IL-2) for enhancing HIV isolation from plasma samples.
- To evaluate the impact of different IL-2 concentrations on HIV detection sensitivity across patient groups.
Main Methods:
- Plasma samples were analyzed for HIV isolation using varying concentrations of exogenous interleukin-2 (IL-2).
- HIV isolation rates and sensitivity were compared between 10 U/ml and 20 U/ml IL-2 groups.
- Sensitivity was assessed in patients stratified by p24 core antigen status.
Main Results:
- A statistically significant increase in HIV isolation rate was observed with 10 U/ml IL-2 compared to 20 U/ml (P = 0.015).
- Sensitivity improved from 0% to 29% in p24 core antigen-negative patients (P = 0.031).
- Sensitivity increased from 71% to 86% in p24 core antigen-positive patients (P > 0.05).
Conclusions:
- 10 U/ml of exogenous interleukin-2 (IL-2) is the optimal concentration for isolating infectious HIV from plasma.
- This concentration significantly enhances HIV detection sensitivity, particularly in individuals with low viral loads or negative p24 antigen status.
Abstract:
A significant increase (P = 0.015) in the HIV isolation rate from plasma samples was achieved by use of 10 U/ml exogenous interleukin-2 compared to 20 U/ml. The sensitivity rose from 0% to 29% in patients negative for p24 core antigen (P = 0.031) and from 71% to 86% in patients positive for p24 core antigen in plasma (P > 0.05). Titration of infectious HIV revealed that 10 U/ml interleukin-2 is the optimal concentration to isolate low numbers of infectious particles of HIV.

